Concepedia

Author

F. Bustin

Centre hospitalier régional de la Citadelle

Also Known As

F Bustin, F. Bustin, Frederique Bustin, Fréderique Bustin, Frédérique Bustin

33

Publications

762

Citations

8

H-Index

14

Concepts

All Affiliations

Centre hospitalier régional de la CitadelleHeidelberg UniversityThe Christie NHS Foundation TrustCliniques Universitaires Saint-LucEli Lilly (United States)
FB

About

F. Bustin is an author at Centre hospitalier régional de la Citadelle specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

485

2

Pharmacology

2

2

420

3

Geriatrics

1

1

53

4

Orthopaedics

1

1

53

5

Aging

1

1

53

F. Bustin

×

7

Publications

721

Citations

7

H-Index

YearCitations

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

Roy S. Herbst, Rafat Ansari, F. Bustin,

The Lancet

2011

391

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

Martin Schüler, James Chih‐Hsin Yang, K. Park,

Annals of Oncology

2015

131

Phase 2, randomized, open‐label study of ramucirumab in combination with first‐line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non–small cell lung cancer

Robert C. Doebele, David R. Spigel, Mustapha Tehfé,

Cancer

2014

84

Final Efficacy and Safety Results of Pemetrexed Continuation Maintenance Therapy in the Elderly from the PARAMOUNT Phase III Study

Cesare Gridelli, Filippo de Marinis, Michael Thomas,

Journal of Thoracic Oncology

2014

53

Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer – EORTC 08062

Mary O’Brien, Krzystof Konopa, Paul Lorigan,

European Journal of Cancer

2011

29

A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting

Laure Sorber, Karen Zwaenepoel, Koen De Winne,

Cancers

2018

21

Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program

Sofie Joris, Thierry Pieters, Anne Sibille,

Journal of Geriatric Oncology

2019

12

Page 1